2014-08-15T13:04:39-05:00 2013-09-30 PricewaterhouseCoopers LLP 125 High Street Boston MA 02110 990 2012-10-01 042103591 MASSACHUSETTS EYE & EAR INFIRMARY % CAROLANN WILLIAMS MASS 6175733942 243 CHARLES STREET Suite BOSTON MA 02114 CAROLANN WILLIAMS 6175733942 2014-07-09 true 6175305000 2012 2015-11-30 17:44:51Z CAROLANN WILLIAMS 243 CHARLES STREET BOSTON MA 02114 221665628 false X WWW.MASSEYEANDEAR.ORG X 1827 MA SEE SCHEDULE O. 21 18 1965 279 0 33572100 39413484 150956667 164905375 665789 1067489 15017611 16279280 200212167 221665628 15552737 16717561 0 0 100490121 106973420 256235 278479 2020705 84181529 98774910 200480622 222744370 -268455 -1078742 236179653 224049415 210336333 187529630 25843320 36519785 X SEE SCHEDULE O. false false 44248600 6979955 164905375 SEE SCHEDULE O 4305552 SEE SCHEDULE O 115469497 9737606 SEE SCHEDULE O 164023649 true true false true false false false true false true true false false true true true false true false false true true false true false false true true true false true true false false false false false true false true false false false false false false false true true true true false true 148 0 true 1965 true false false false false false false false false false false X 21 18 false false false false false true true true true false false true true true true true true true true false MA NY X CAROLANN WILLIAMS 6175733012 243 CHARLES STREET BOSTON MA 02114 X JOHN R FERNANDEZ 37.0 23.0 X X 810694 0 155041 WYCLIFFE GROUSBECK 3.0 7.0 X X JONATHAN UHRIG 3.0 7.0 X X LILY H BENTAS 3.0 7.0 X X RICHARD H ALDRICH 2.0 2.0 X DEWALT PETE ANKENY 2.0 6.0 X JAMES CARLISLE 2.0 2.0 X CHARLES DE GUNZBERG 2.0 6.0 X SAMUEL FLEMING 2.0 2.0 X HARVEY FREISHTAT 2.0 2.0 X LYLE HOWLAND 2.0 2.0 X DIANE E KANEB 2.0 2.0 X JONATHAN KUTCHINS 2.0 4.0 X VICTORIA MCCULLOUGH 2.0 6.0 X JOAN W MILLER MD 27.0 33.0 X 0 781005 56306 JOSEPH B NADOL JR MD 29.0 31.0 X 0 782173 62754 ANNETTE NOVA 2.0 6.0 X WILLIAM ROMAN 2.0 2.0 X FREDERICK THORNE 2.0 2.0 X KATHRYN VECELLIO 2.0 6.0 X EUGENE HILL 2.0 2.0 X SUSAN WILLIAMS 49.0 11.0 X 268612 0 19064 MAUREEN KELLEY 53.0 7.0 X 172383 0 28262 CAROLANN WILLIAMS 49.0 11.0 X 360843 0 11502 BARBARA J SCULLY 30.0 30.0 X 169929 0 34459 EILEEN O LOWELL 60.0 0.0 X 241312 0 33911 ALAN K LONG 30.0 30.0 X 221708 0 8547 CHRISTINE REGAN 60.0 0.0 X 237749 0 35375 KENNETH HOLMES 30.0 30.0 X 295103 0 28619 JEAN E MACQUIDDY 30.0 30.0 X 250249 0 33842 JEFFREY J PIKE 60.0 0.0 X 346471 0 18943 JAVIER BALLOFFET 20.0 40.0 X 313354 0 36405 RALPH T PELOSI 60.0 0.0 X 173928 0 6476 JENNIFER STREET 60.0 0.0 X 339166 0 33000 MELISSA M PAUL 60.0 0.0 X 229495 0 36135 GLENN W BUNTING 60.0 0.0 X 178115 0 38210 GREGORY J DONNELLY 60.0 0.0 X 176560 0 30597 PHILLIP C JOHNSON 60.0 0.0 X 189622 0 39519 PETER J CHINETTI 0.0 0.0 X 110893 0 225 ALEC CHELOFF 60.0 0.0 X 187203 0 19628 5273389 1563178 766820 169 true true false TSOIKOBUS ASSOCIATES 1 BRATTLE SQUARE PO BOX 9114 CAMBRIDGE MA 02238 ARCHITECTS 529047 CG ASSOCIATES 7 CHUCK DRIVE DRACUT MA 01826 CONSTRUCTION 561339 FISH RICHARDSON PC PO BOX 3295 BOSTON MA 02241 LEGAL 419419 LFREP SERVICES LLP 260 FRANKLIN ST BOSTON MA 02110 CONSULTING SERVICES 285900 PRICEWATERHOUSECOOPERS PO BOX 7247-8001 PHILADELPHIA PA 19170 AUDIT 272079 5 11585707 17262316 10565461 39413484 INPATIENT AND OUTPATIENT 900099 144676161 144676161 MISCELLANEOUS REVENUE 900099 6368497 6368497 RESEARCH OVERHEAD 900099 6680683 6680683 HEARING AID CENTERS 900099 3711822 3711822 CAFETERIA/FOOD SERVICE 722210 1815212 1815212 1653000 1653000 164905375 91517 91517 0 16279280 16279280 0 0 0 975972 975972 975972 975972 0 0 0 0 221665628 164905375 17346769 X 16535926 16535926 0 0 181635 181635 0 0 3391691 1088011 2303680 0 0 80352122 60331408 18939317 1081397 1518870 1120793 374686 23391 15203484 11419588 3542826 241070 6507253 4801786 1605256 100211 0 0 881161 613336 267825 0 428765 166000 262765 0 212652 0 212652 0 278479 278479 0 0 3509030 3273725 235305 0 1094568 23120 1071448 0 2042436 1069607 857921 114908 2707950 0 2707950 0 0 0 9174698 944396 8230302 0 909403 656187 209351 43865 0 0 0 0 2038999 1415063 623936 0 0 18645562 12940000 5705562 0 1114170 66652 1047518 0 MEDICAL SUPPLIES 32239713 32140697 99016 0 PHYSICIANS ADMINISTRATION 5962667 5893359 69308 0 MISCELLANEOUS 8110779 5217525 2778335 114919 ALL OTHER EXPENSES 9702357 4124835 5555057 22465 222744370 164023649 56700016 2020705 84562 1374003 0 0 0 0 20951960 21380084 20000 10000 0 0 0 0 2155473 2302498 3862909 4078975 375862839 237421178 133268256 138441661 0 0 0 0 0 0 0 0 75836493 56462194 236179653 224049415 80079903 70433190 0 0 37959380 25513725 86480956 83647571 0 0 0 0 0 0 0 0 5816094 7935144 210336333 187529630 X 25843320 36519785 0 0 0 0 25843320 36519785 236179653 224049415 X -1078742 -126562 11881769 X false true X true true true X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false true false false true 212652 false false 212652 false SCHEDULE C, PART II-B, LINE 1(I): DURING THE FISCAL YEAR ENDED SEPTEMBER 30, 2013, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") PAID A CONSULTANT TO ASSIST THE INFIRMARY ON BEHALF OF ITSELF AND ITS AFFILIATES, WITH DEVELOPING MEETINGS WITH THE MEMBERS OF THE MASSACHUSETTS LEGISLATURE AND EXECUTIVE BRANCH FOR PURPOSES OF DISCUSSION AROUND STATE HEALTHCARE PAYMENT REFORM, DISCUSSION AROUND MASSACHUSETTS EYE AND EAR REAL ESTATE DEVELOPMENT PLANNING, ASSIST IN PREPARING TESTIMONY FOR PRESENTATION BEFORE ALL RELEVANT COMMITTEES OF THE MASSACHUSETTS GENERAL COURT; DEVELOP LEGISLATIVE STRATEGIES; SERVE AS LIAISON TO GOVERNMENT AGENCIES AS NECESSARY AND MONITOR AND REPORT ON GOVERNMENT PROGRAMS RELATIVE TO HEALTHCARE FINANCING, INCLUDING STATE APPROPRIATIONS AND GRANTS. THE INFIRMARY IS A MEMBER OF CERTAIN TRADE ASSOCIATIONS THAT MAY LOBBY ON ITS BEHALF. X X X X false 89724541 2692680 3521682 7238556 1495683 87204664 86399272 1269332 6139492 2803513 1280042 89724541 60472244 29640100 1622561 4005052 1330581 86399272 60355993 736023 4138384 3579845 1178311 60472244 60792309 993556 3611396 3713026 1328242 60355993 0.08553 0.59035 0.32411 false true true 535324 535324 176467311 106372037 70095274 15196635 1332442 13864193 176275184 129661303 46613881 7388385 55396 7332989 138441661 DUE FROM AFFILIATES 29070759 FUNDS HELD FOR RESEARCH 3731041 CONSTRUCTION FUND 8751806 DEBT SERVICE FUND 174704 SPECIAL CASH & CAPITAL RESERVE 4163350 DEBT SERVICE RESERVES FUND 6042298 DEFERRED FINANCING COSTS 1540877 CAPITALIZED INTEREST 0 TAX DEFERRED PLAN 971900 CRICO 2015459 56462194 0 DUE TO AFFILIATES 215522 ESTIMATE THIRD PARTY SETTLEMEN 4218998 PROFESSIONAL LIABILITY RESERVE 2528724 ASSET RETIREMENT OBLIGATION 0 TAX DEFERRED LIABILITY 971900 7935144 X SCHEDULE D, PART III, LINE 4: THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN EACH SPECIALTY OF THE EYE AND EAR AND BOOKS PURCHASED LATER WITH FUNDS FROM ENDOWMENTS SET UP BY THE PEOPLE WHO DONATED THE ORIGINAL COLLECTIONS. THE RARE BOOKS ARE AVAILABLE TO THE SCIENTIFIC, MEDICAL AND ACADEMIC COMMUNITY FOR PURPOSES OF RESEARCH AND EDUCATION. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE. SCHEDULE D, PART X, LINE 2: THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2013. true Europe (Including Iceland and Greenland) Program Services Research 127843 North America Program Services Research 53647 Central America and the Caribbean Investments 24200 North America Program Services Conference 2557 South America Program Services Conference 1451 East Asia and the Pacific Program Services Conference 9832 Europe (Including Iceland and Greenland) Program Services Conference 74374 South Asia Program Services Conference 28982 Middle East and North Africa Program Services Conference 295 323181 323181 Europe (Including Iceland and Greenland) 127988 check 0 North America 53647 CHECK 0 false false true false false false SCHEDULE F, PART I, LINE 2: SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE INFIRMARY ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A STATISFACTORY PACE. SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1: THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER. X X X X X true PURSUANT ANNUAL FUND false 85542 BRAKELEY BRISCO CAPITAL CAMPAIGN false 11291 VISION PHILANTHROPY GROUP CAPITAL CAMPAIGN false 130824 227657 ME MA NY SCHEDULE G, PART I, LINE 2B, COLUMN (V): DURING THE FISCAL YEAR ENDED SEPTEMBER 20, 2013, THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH PURSUANT, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PAITENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH BRAKELEY BRISCOE AND VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN. true true true X 400. true X true true true false true true 3500688 103938 3396750 0.01520 13547737 11201367 2346370 0.01050 3861948 3775107 86841 0.00040 20910373 15080412 5829961 0.02610 452931 0 452931 0.00200 7136496 1450476 5686020 0.02550 2 624 1907390 1504778 402613 0.00180 38753403 946746 37806657 0.16970 0 0 0 0.00000 2 624 48250220 3902000 44348221 0.19900 2 624 69160593 18982412 50178182 0.22510 true 2681043 9648 39144941 43530661 -4385720 X true true 1 1 MASSACHUSETTS EYE & EAR INFIRMARY

243 CHARLES STREET BOSTON MA 02114

http://www.masseyeandear.org/ X X X X MASSACHUSETTS EYE & EAR INFIRMARY true X X X X X X X X 13 true false X X X X X X X X X X false false true true 400. true 400. true X X X X X X X true true X X X X X X true false true X false false 7 MASSACHUSETTS EYE & EAR STONEHAM

ONE MONTVALE AVENUE STONEHAM MA 02180

LICENSED OUTPATIENT LOCATION MASSACHUSETTS EYE & EAR E BRIDGEWATER

ONE COMPASS WAY SUITE 100 E BRIDGEWATER MA 02333

LICENSED OUTPATIENT LOCATION MEEI VESTIBULAR CENTER AT BRAINTREE

250 POND STREET 1ST FLOOR BRAINTREE MA 02184

LICENSED OUTPATIENT LOCATION MASSACHUSETTS EYE & EAR QUINCY

500 CONGRESS STREET QUINCY MA 02169

LICENSED OUTPATIENT LOCATION MASSACHUSETTS EYE & EAR AT JOSLIN

1 JOSLIN PLACE BOSTON MA 02215

LICENSED OUTPATIENT LOCATION MASSACHUSETTS EYE & EAR CONCORD

54 BAKER AVE EXTENSION 3RD FL STE CONCORD MA 01742

LICENSED OUTPATIENT LOCATION MASSACHUSETTS EYE & EAR LONGWOOD

800 HUNTINGTON AVENUE BOSTON MA 02115

LICENSED OUTPATIENT LOCATION SCHEDULE H, PART II: THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND IT'S AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 16 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS. SCHEDULE H, PART III, LINE 4: BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT. SCHEDULE H, PART III, LINE 8: THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER. SCHEDULE H, PART III, LINE 9B: PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE. Schedule H, Part V, Section B, Line 3: To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 5A: The community health needs assessment can be found online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 40 young adults receive exams through vision coalition. -At least 50 people will receive support for and education about glaucoma. Only 43 people received education from annual glaucoma support group before group disbanded during the fiscal year. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least one individual will receive reconstructive surgery to address injuries caused by domestic violence. Hospital did not receive any referrals from the R.O.S.E. in FY13. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 45 people were screen at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS. SCHEDULE H, PART VI, LINE 2: MEEI ENGAGED THE SERVICES OF CONSULTANTS TO WORK CLOSELY WITH THE COMMUNITY BENEFITS (BC) WORKING GROUP THROUGHOUT THE ASSESSMENT AND PLANNING PROCESS, WHICH TOOK PLACE DURING THE FALL 2012/WINTER 2013. DURING THE ASSESSMENT AND PLANNING PROCESSES, THE CB WORKING GROUP MET REGULARLY AND ENGAGED THE FULL COMMITTEE AS NEEDED FOR PROGRESS UPDATES AND INPUT. AFTER THE PLAN WAS DEVELOPED AND APPROVED, MEETINGS DECREASED IN FREQUENCY AND THE GROUPS MET ON AN AS-NEEDED BASIS. FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILALBE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MEEI'S CB COMMITTEE HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN. SCHEDULE H, PART VI, LINE 3: MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A LINK WHICH HIGHLIGHTS THE BASIC FEDERAL PROGRAMS AND ACCESS TO MEEI'S FINANCIAL COUNSELORS. THE FINANCIAL COUNSELING PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED. SCHEDULE H, PART VI, LINE 4: STEP 1: IDENTIFY MEEI'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MEEI COMMUNITY BENEFIT PLANS BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2011 THROUGH MARCH 31, 2012) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 65,429 PATIENTS. BELOW, OBSERVATIONS ABOUT PATIENTS' SEX, RACE/ETHNICITY, AGE, SOCIO-ECONOMIC STATUS, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. DEMOGRAPHIC CATEGORIES & STATISTICS: SEX: OVER HALF (53.4%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 75% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT THE HOSPITAL. FIGURE 1 BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (60.2%) ARE WHITE. RACIAL/ETHNIC BREAKDOWN: (NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS) AMERICAN INDIAN/ALASKA NATIVE: 125; 0.2% ASIAN: 2,196; 3.4% BLACK/AFRICAN AMERICAN: 4,684; 7.2% HISPANIC: 1,090; 1.7% PACIFIC ISLANDER: 25; <1% WHITE: 39,392; 60.2% OTHER: 1,148; 1.7% UNKNOWN: 16,769; 25.6% TOTAL: 65,429; 100% BECAUSE THERE IS SO MUCH MISSING INFORMATION ABOUT RACE/ETHNICITY, THE DATA WERE NOT PARTICULARLY USEFUL IN IDENTIFYING VULNERABLE POPULATIONS. GEOGRAPHY: NOTE THAT WITHIN DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTON'S 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 11 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 11 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MEEI PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MEEI PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. OF THE 65,429 MASSACHUSETTS PATIENTS IN THE DATA SET, NEARLY 30% LIVE IN BOSTON AND NEARLY HALF (49.2%) LIVE IN COMMUNITIES INSIDE ROUTE 128 (INCLUDING BOSTON). THE VAST MAJORITY (82.8%) OF PATIENTS ARE FROM COMMUNITIES INSIDE OF ROUTE 495. PERCENT OF MEEI PATIENTS LIVING IN GEOGRAPHIC AREAS OF MASSACHUSETTS: BOSTON/BOSTON NEIGHBORHOODS: 29.5% WITHIN 128 (EXCEPT BOSTON): 19.7% NORTH SHORE: 3.2% INSIDE 495 (BEYOND 128): 30.4% OUTSIDE 495 - CENTRAL: 6.6% OUTSIDE 495 - NORTH: 4.5% WESTERN MA: 5.1% CAPE/ISLANDS: <1% TO IDENTIFY POPULATION CENTERS, THE CONSULTANTS LOOKED FOR THE COMMUNITIES/NEIGHBORHOODS IN WHICH THE LARGEST NUMBERS OF MEEI PATIENTS LIVE. FIFTEEN COMMUNITIES/NEIGHBORHOODS ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS. NEARLY HALF (49.9%) LIVE IN THESE 15 COMMUNITIES. MASSACHUSETTS COMMUNITIES/NEIGHBORHOODS WITH HIGHEST PROPORTION OF MEEI PATIENTS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS; GEOGRAPHIC AREA) BOSTON (NO COMMUNITY SPECIFIED): 12,575; 19.2%; BOSTON JAMAICA PLAIN: 1,007; 1.5%; BOSTON WEST ROXBURY: 817; 1.2%; BOSTON ROSLINDALE: 789; 1.2%; BOSTON HYDE PARK: 780; 1.2%; BOSTON ALLSTON/BRIGHTON: 1,414; 2.2%; BOSTON CHARLESTOWN: 1,188; 1.8%; BOSTON CAMBRIDGE: 4,037; 6.2%; WITHIN 128 LYNN: 3,941; 6.0%; WITHIN 128 WAKEFIELD: 911; 1.4%; WITHIN 128 WOBURN: 933; 1.4%; WITHIN 128 READING/N. READING: 1,180; 1.8%; INSIDE 495 ANDOVER/N. ANDOVER: 1,356; 2.1%; INSIDE 495 FRAMINGHAM: 941; 1.4%; INSIDE 495 WORCESTER: 752; 1.1%; OUTSIDE 495 AGE: THE MASSACHUSETTS ATTORNEY GENERAL IS INTERESTED IN HAVING THE HOSPITAL COMMUNITY BENEFITS PLANS TARGET VULNERABLE POPULATIONS. MEEI HAS CLINICAL EXPERTISE IN SERVING ELDERS AND CHILDREN, POTENTIALLY VULNERABLE POPULATIONS SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MEEI'S COMMUNITY BENEFITS PLAN BECAUSE OF THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. THE MEAN AGE OF MEEI PATIENTS IS 46.81 YEARS, WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 106 YEARS OF AGE. PATIENTS AGED 65 AND OVER MAKE UP 23.5% OF THOSE SEEN DURING THE SELECTED TIMEFRAME, WHEREAS THOSE 18 OR YOUNGER CONSTITUTE 13.7% OF THE POPULATION. BELOW SHOWS THE PROPORTION OF PATIENTS IN VARIOUS AGE GROUPS: (AGE GROUP: PERCENTAGE OF TOTAL) <1 YEAR TO 18 YEARS OLD: 13.7% 19 TO 24 YEARS OLD: 5.4% 25 TO 34 YEARS OLD: 10.6% 35 TO 44 YEARS OLD: 12.2% 45 TO 54 YEARS OLD: 16.3% 55 TO 64 YEARS OLD: 18.3% 65 AND OVER: 23.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBER OF MEEI'S SENIOR (65 YEARS AND OLDER) POPULATION. THESE TEN COMMUNITIES ARE HOME TO 34% OF MEEI SENIORS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,820; 11.8% CAMBRIDGE: 1,015; 6.6% DORCHESTER: 540; 3.5% LYNN: 386; 2.5% BRIGHTON: 298; 1.9% FRAMINGHAM: 261; 1.7% JAMAICA PLAIN: 238; 1.5% PEABODY: 237; 1.5% SAUGUS: 227; 1.5% WOBURN: 227; 1.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO ARE LESS THAN 1 YEAR OF AGE THROUGH AGE 18. NEARLY 30% OF THE CHILDREN SERVED BY MEEI DURING THE DESIGNATED TIME PERIOD LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 883; 9.9% LYNN: 370; 4.1% CAMBRIDGE: 350; 3.9% SAUGUS: 192; 2.1% CHARLESTOWN: 175; 2.0% WOBURN: 169; 1.9% HAVERHILL: 143; 1.6% ANDOVER: 141; 1.6% DORCHESTER: 131; 1.4% READING: 129; 1.4% SOCIO-ECONOMIC STATUS: SOCIO-ECONOMIC (SES) IS ANOTHER VARIABLE ASSOCIATED WITH VULNERABLE POPULATIONS. PATIENTS' HEALTH INSURANCE CAN BE USED AS A PROXY FOR SES BECAUSE THERE ARE INCOME ELIGIBILITY REQUIREMENTS IN PLACE FOR PUBLIC PAYERS THAT ALLOW US TO MAKE ASSUMPTIONS ABOUT WHICH PATIENTS ARE LOW INCOME. IT IS IMPORTANT TO NOTE THAT THE NUMBER OF LOW-INCOME PATIENTS SERVED BY MEEI IS LIKELY MUCH HIGHER. IT IS NOT POSSIBLE TO KNOW HOW MANY MASSHEALTH PATIENTS, FOR EXAMPLE, ARE INSURED THROUGH A COMMERCIAL CARRIER WITH A MANAGED CARE CONTRACT WITH MASSHEALTH. ADDITIONALLY, IT IS NOT POSSIBLE TO KNOW WHICH PORTION OF THE SENIORS USING MEDICARE PRODUCTS TO PAY FOR THE SERVICES THEY RECEIVE AT MEEI ARE LOW-INCOME AND WHICH ARE NOT. ALTHOUGH AN IMPERFECT METHOD FOR DETERMINING THE SES OF PATIENTS, THESE ARE THE BEST DATA AVAILABLE FOR THIS PURPOSE. USING PAYER AS PROXY, IT APPEARS THAT JUST OVER 11% OF THE MEEI PATIENTS ARE LOW-INCOME, BROKEN DOWN AS FOLLOWS: (PUBLIC PAYER: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) MASSHEALTH: 3,672; 7.1% HEALTH SAFETY NET: 796; 1.2% MEDICAID: 287; 0.4% BMC HEALTH NET: 143; 0.2% NETWORK HEALTH: 1,493; 2.3% THE AVERAGE AGE OF THESE LOW-INCOME PATIENTS IS 37 WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 96 YEARS OF AGE. IT IS IMPORTANT TO NOTE THAT THE VAST MAJORITY OF SENIORS (65+) ARE EXCLUDED FROM THE ANALYSES BECAUSE MOST SENIORS USE MEDICARE PRODUCTS TO PAY FOR THEIR CARE. TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO HAVE LOW SES. NEARLY 50% OF THE PATIENTS WITH LOW SES LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,102; 17.2% LYNN: 504; 7.9% CAMBRIDGE: 440; 6.9% DORCHESTER: 248; 3.8% LAWRENCE: 198; 3.1% CHARLESTOWN: 160; 2.5% EAST BOSTON: 163; 2.2% SAUGUS: 129; 2.0% LOWELL: 127; 2.0% WORCESTER: 123; 1.9% MEEI SERVES A POPULATION WITH A LARGE AGE RANGE, INCLUDING SIGNIFICANT SENIOR (65+) AND PEDIATRIC (LESS THAN ONE YEAR THROUGH AGE 18) POPULATIONS. USING PATIENT PAYER AS A PROXY FOR SES, AT LEAST 11.2% OF THE PATIENTS HAVE LOW SES. NEARLY HALF OF MEEI'S PATIENTS LIVE IN COMMUNITIES WITHIN ROUTE 128, INCLUDING BOSTON AND SELECT NEIGHBORHOODS. ELEVEN OF THE 15 COMMUNITIES THAT ARE HOME TO THE LARGEST CONCENTRATION OF MEEI PATIENTS ARE WITHIN THIS GEOGRAPHIC AREA. THERE IS OVERLAP IN THE TOP COMMUNITIES FOR THE GENERAL POPULATION OF PATIENTS SEEN DURING THE DESIGNATED TIMEFRAME AND THE VULNERABLE POPULATIONS. THREE ARE AMONG THE TOP COMMUNITIES FOR THE OVERALL POPULATION AND ELDERS, CHILDREN AND THOSE WITH LOW-SES: BOSTON, CAMBRIDGE AND LYNN. TWO OTHERS (DORCHESTER AND SAUGUS) ARE AMONG THE TOP TEN FOR ALL THREE VULNERABLE GROUPS. IT MAY BE POSSIBLE TO MAXIMIZE RESOURCES FOR ADDRESSING THE NEEDS OF PATIENTS OVERALL AND AMONG THE VULNERABLE POPULATIONS BY CONCENTRATING EFFORTS IN COMMUNITIES/NEIGHBORHOODS WITHIN 128, ESPECIALLY THOSE WHERE SUCH OVERLAPS EXIST. A 2010 CENSUS MAP PRODUCED BY THE BOSTON GLOBE AND AVAILABLE ON-LINE SHOWS THAT THE LARGEST CONCENTRATION OF PEOPLE OF COLOR IN MASSACHUSETTS IS IN THE METRO BOSTON AREA. A SIMILAR 2010 CENSUS MAP SHOWS THAT, ALTHOUGH METRO BOSTON IS HOME TO SOME OF THE COMMONWEALTH'S WEALTHIEST COMMUNITIES, IT IS ALSO HOME TO SOME OF THE LOWEST INCOME COMMUNITIES. A THIRD MAP CREATED BY THE GERONTOLOGY INSTITUTE AT THE MCCORMACK GRADUATE SCHOOL OF POLICY AND GLOBAL STUDIES AT THE UNIVERSITY OF MASSACHUSETTS BOSTON SHOWS THAT THE POPULATION OF SENIORS LIVING WITHIN THE METRO BOSTON AREA EXCEEDS THE STATEWIDE AVERAGE. ACCORDING TO THE 2010 CENSUS, 13.8% OF MASSACHUSETTS RESIDENTS ARE AGED 65 AND OLDER. WITHIN THE MAJORITY OF METRO BOSTON COMMUNITIES, SENIORS COMPRISE BETWEEN 15.1% AND 20% OF THE CITY/TOWN POPULATIONS. CONCLUSIONS: BASED ON THE MOST RECENT CENSUS DATA AND MEEI'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MEEI CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITAL'S PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES IN THE METRO-BOSTON AREA (WITHIN THE ROUTE 128 BELT). ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF VULNERABLE (I.E., CHILDREN, ELDERLY AND LOW-INCOME) PATIENTS RESIDE WITHIN THE METRO-BOSTON/128 AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MEEI'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. BECAUSE OF THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS PARTICULARLY VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MEEI SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN. STEP 2: ASSESS UNMET NEEDS IN METRO BOSTON AND AMONG THE TARGET POPULATIONS THE CB WORKING GROUP, OTHER MEMBERS OF THE COMMUNITY BENEFITS COMMITTEE, OTHER PROVIDERS AND STAFF AT MEEI, AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES WORKED TOGETHER TO UNDERSTAND THE UNMET NEEDS THAT, AS AN INSTITUTION, MEEI IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE SUMMER AND FALL OF 2012, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE CONSISTENT WITH THOSE IDENTIFIED IN THE 2010 COMMUNITY BENEFITS PLAN: -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF DOMESTIC VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK AS A RESULT OF ABUSE. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MEEI SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF COMMUNITY-BASED NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN POVERTY OVER THE LAST SEVERAL YEARS, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MEEI WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF MEEI AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. STEP 3: ASSESS NEEDS IN MISSION HILL AS NOTED EARLIER, MEEI DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN MISSION HILL, THE NEIGHBORHOOD IN WHICH ITS NEW OUT-PATIENT FACILITY IS LOCATED. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. JUST OVER 44% OF RESIDENTS SPEAK A LANGUAGE OTHER THAN OR IN ADDITION TO ENGLISH. OF THOSE WHO SPEAK A LANGUAGE OTHER THAN ENGLISH, 33.2% ARE LINGUISTICALLY ISOLATED BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER-OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH, HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME FAMILIES. SENIORS AND CHILDREN MAKE UP ROUGHLY 30% OF THE MISSION HILL POPULATION. TO LEARN ABOUT MEEI'S PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MEEI CARED FOR 263 PATIENTS WHO LIVE IN MISSION HILL (1.6% OF THE MISSION HILL POPULATION). WITH THE NEW FACILITY IN MISSION HILL AND A CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THAT NUMBER TO RISE OVER THE NEXT THREE YEARS. (SEE FIGURE 11 IN THE OFFICIAL MEEI COMMUNITY BENEFITS REPORT FOR THE DEMOGRAPHICS OF MEEI'S PATIENTS WHO LIVE IN MISSION HILL.) AFTER PROFILING THE DEMOGRAPHICS OF THE NEIGHBORHOOD, THE CONSULTANTS INTERVIEWED TWO SENIOR MANAGERS FOR COMMUNITY BENEFITS AT BRIGHAM AND WOMEN'S HOSPITAL (BWH). BWH IS LOCATED IN THE LONGWOOD MEDICAL AREA, NEIGHBORING MISSION HILL, AND HAS AN EXTENSIVE COMMUNITY BENEFITS PROGRAM THAT INVOLVES NUMEROUS INITIATIVES IN THE MISSION HILL. BOTH SENIOR MANAGERS HAVE SIGNIFICANT EXPERIENCE WORKING IN MISSION HILL AND WERE ABLE TO PROVIDE AN OVERVIEW OF BWH'S EXPERIENCE IN THE NEIGHBORHOOD. BOTH SENIOR MANAGERS SHARED A SYNOPSIS OF FINDINGS FROM THEIR OWN COMMUNITY BENEFITS NEEDS ASSESSMENT IN MISSION HILL. TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MEEI CB WORKING GROUP AND WITH BRIGHAM AND WOMEN'S HOSPITAL COMMUNITY BENEFITS LEADERS TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. THE INTERVIEW DATA WERE ANALYZED FOR COMMON AND DIVERGENT THEMES, WHICH ARE SUMMARIZED BELOW. MISSION HILL WAS DESCRIBED AS A COMMUNITY OF HIGH ECONOMIC NEED AND ONE IN WHICH JOB CREATION, JOB TRAINING, AND YOUTH EMPLOYMENT ARE HIGH PRIORITIES. THE KEY INFORMANTS DESCRIBED MISSION HILL RESIDENTS AS CULTURALLY AND LINGUISTICALLY DIVERSE WITH LARGE POPULATIONS OF HISPANIC, CHINESE, RUSSIAN, SOMALI, AND ETHIOPIAN RESIDENTS. THE COMMUNITY IS ALSO HOME TO A NUMBER OF HIGHLY DEDICATED ADVOCATES WHO ARE DEEPLY COMMITTED TO WORKING WITH INSTITUTIONAL NEIGHBORS TO BENEFIT THE NEIGHBORHOOD AND TO RESOLVE ISSUES AS THEY ARISE. MEEI IS VIEWED IN A POSITIVE LIGHT AND WAS OVERWHELMINGLY WELCOMED TO THE NEIGHBORHOOD. ALL OF THE KEY INFORMANTS EXPRESSED A SINCERE DESIRE TO HELP MEEI AS THE HOSPITAL BECOMES FAMILIAR WITH THE COMMUNITY AND INTRODUCES COMMUNITY BENEFITS PROGRAMS. MISSION HILL RESIDENTS ACCESS ROUTINE HEALTH CARE SERVICES FROM MANY SOURCES, INCLUDING THE LOCAL HOSPITAL PRIMARY CARE PRACTICES, COMMUNITY HEALTH CENTERS AND HOSPITAL EMERGENCY ROOMS. DIABETES WAS IDENTIFIED AS A PARTICULAR HEALTH ISSUE OF CONCERN IN MISSION HILL. THE KEY INFORMANTS REPORTED THAT VISION AND HEARING ISSUES ARE NOT ADDRESSED IN A COMPREHENSIVE MANNER IN THE COMMUNITY AND THAT A NEED FOR SUCH CARE EXISTS. THE KEYS TO BUILDING AND SUSTAINING STRONGLY RELATIONSHIPS IN THE COMMUNITY WERE DESCRIBED AS: -BEING A GOOD AND RESPECTFUL NEIGHBOR TO THOSE WHO ABUT THE NEW MEEI FACILITY, INCLUDING HAVING REGULAR DIALOGUE WITH THEM. -HAVING A PRESENCE IN MISSION HILL BY ATTENDING EVENTS. -HAVING A POINT PERSON/LIAISON TO THE NEIGHBORHOOD BEING RESPONSIVE AS NEEDS OR ISSUES ARISE -BEING INCLUSIVE, WORKING TO SERVE THE BROADER COMMUNITY RATHER THAN SPECIFIC ORGANIZATIONS WITHIN IT. -TAKING ADVANTAGE OF OPPORTUNITIES TO PARTNER WITH ORGANIZATIONS AND ADVOCATES IN MISSION HILL, INCLUDING MIKE ROSS, BOSTON CITY COUNCILMAN, WHO LIVES IN MISSION HILL. THE KEY INFORMANTS IDENTIFIED A NUMBER OF NEEDS THAT ARE CONSISTENT WITH MEEI'S CLINICAL EXPERTISE AND COMMUNITY BENEFITS MISSION, INCLUDING: -VISION/HEARING SCREENINGS FOR SENIORS AND FOR CHILDREN (TO COMPLEMENT SCREENINGS OFFERED BY THE BOSTON PUBLIC SCHOOLS) -FOLLOW UP CARE FOR SENIORS AND CHILDREN, INCLUDING FREE/REDUCED COST EYE GLASSES AND HEARING AIDS -EDUCATIONAL PROGRAMS/MATERIALS: -SENIORS: VISION CARE, ESPECIALLY RELATED TO DIABETES, BALANCE/FALLS PREVENTION, HEAD AND NECK ISSUES -YOUTH: HEARING ISSUES RELATED TO PORTABLE DEVICES AND HEADPHONES -TEACHERS: DETECTING HEARING AND VISION ISSUES AMONG STUDENTS AND THE RELATIONSHIP BETWEEN HEARING AND SPEECH. THE INTERVIEW PARTICIPANTS ALSO TALKED ABOUT THE NEED FOR ADDITIONAL JOB TRAINING/EMPLOYMENT OPPORTUNITIES, PARTICULARLY FOR YOUTH. SUGGESTIONS INCLUDED SUMMER JOBS FOR YOUTH, PAID INTERNSHIPS FOR YOUNG PEOPLE, EMPLOYMENT FOR MISSION HILL RESIDENTS AT THE MEEI MAIN CAMPUS AND THE MISSION HILL LOCATION, AND SCHOLARSHIP CONTRIBUTIONS. THE KEY INFORMANTS RECOMMENDED THAT MEEI "PIGGY BACK" ON EXISTING EFFORTS IN MISSION HILL TO REACH THE TARGET POPULATION FOR COMMUNITY BENEFITS INITIATIVES, GOING TO THE PLACE WHERE YOUTH AND SENIORS ALREADY TEND TO MEET (E.G., THE TOBIN COMMUNITY CENTER). THEY ALSO RECOMMENDED WORKING WITH ORGANIZATIONS THAT REPRESENT SENIORS AND CHILDREN FROM ACROSS MISSION HILL (E.G., THE LEGACY PROJECT, THE MISSION HILL YOUTH COLLABORATIVE) TO REACH THE MAXIMUM NUMBER OF YOUNG PEOPLE AND ELDERS IN THE COMMUNITY. THE ORGANIZATIONS IN MISSION HILL HAVE WELL-ESTABLISHED METHODS FOR COMMUNICATING WITH ONE ANOTHER AND WITH RESIDENTS ABOUT EVENTS IN THE COMMUNITY. ALTHOUGH SEVERAL USE EMAIL TO COMMUNICATE WITH THEIR COLLEAGUES IN OTHER ORGANIZATIONS, MOST ALSO DISSEMINATE FLYERS IN THE COMMUNITY TO ADVERTISE PROGRAMMING TO RESIDENTS. SOME ALSO USE PHONE TREES AND GO DOOR TO DOOR. NEWSLETTERS, CALENDARS, MONTHLY ORGANIZATION MEETINGS, AND THE LOCAL NEWSPAPER, THE MISSION HILL GAZETTE, ARE OTHER METHODS FOR SPREADING THE WORD IN MISSION HILL. ALL OF THE KEY INFORMANTS OFFERED TO HELP MEEI PUBLICIZE ITS COMMUNITY BENEFITS OFFERINGS THROUGH THEIR ESTABLISHED LINES OF COMMUNICATION. CONCLUSIONS: BASED ON THE FINDINGS FROM THE NEEDS ASSESSMENT IN MISSION HILL, THE COMMUNITY BENEFITS COMMITTEE DECIDED THAT IN EACH OF THE NEXT THREE YEARS, THE HOSPITAL'S COMMUNITY BENEFITS STRATEGIES IN THE NEIGHBORHOOD WILL INCLUDE THE FOLLOWING: -WORKING WITH THE MISSION HILL LEGACY PROJECT, OFFER A FREE VISION SCREENING TO AT LEAST 25 SENIORS AT ITS NEW LONGWOOD CENTER -WORKING WITH THE TOBIN COMMUNITY CENTER, PROVIDE A FREE EDUCATIONAL SESSION FOR YOUTH ON HEARING LOSS PREVENTION AT THE TOBIN COMMUNITY CENTER LOCATION. (IF IN YEARS 2 AND 3 OF THE PLAN, MEEI AND ITS COMMUNITY PARTNERS DETERMINE THAT SOMETHING DIFFERENT THAN THE ANNUAL VISION SCREENING FOR SENIORS OR HEARING EDUCATION EVENT FOR YOUTH IS NEEDED/PREFERABLE, THE PLAN WILL BE EDITED TO REFLECT SUCH CHANGES. THE OTHER COMMUNITY BENEFITS STRATEGIES ARE LIKELY TO OCCUR IN EACH OF THE THREE YEARS OF THE PLAN.) -WORKING WITH ONE OF THE EXISTING YOUTH EMPLOYMENT PARTNERS OR THE MISSION HILL YOUTH COLLABORATIVE, PROVIDE AN INTERNSHIP OPPORTUNITY TO A YOUNG PERSON IN MISSION HILL AT THE LONGWOOD FACILITY. -CONTINUE TO SUPPORT THE MISSION HILL MAIN STREET ROAD RACE (IN THE FORM OF AN ANNUAL $1000 SPONSORSHIP. -PARTICIPATE IN THE MISSION HILL HEALTH FAIR THAT IS HELD IN JUNE TO PROVIDE INFORMATION ON THE HOSPITAL AND PREVENTION AND TREATMENT OF CLINICAL ISSUES OF THE HEAD AND NECK. -ASSIST THOSE IN NEED OF FOLLOW UP CARE, INCLUDING HEARING AIDS AND GLASSES, TO OBTAIN COVERAGE FOR WHICH THEY ARE ELIGIBLE OR TO ACCESS ASSISTANCE THROUGH THE HOSPITAL (E.G., CHARITABLE CARE, FREE/REDUCE COST EYEGLASSES OR HEARING AID PROGRAMS). MEEI FILES AN ANNUAL COMMUNITY BENEFITS REPORT WITH THE MASSACHUSETTS ATTORNEY GENERAL. WHEN THE REPORTS ARE POSTED, THEY ARE AVAILABLE HERE: HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH/ SCHEDULE H, PART VI, LINE 5: MEEI'S COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. SCREENING AND CLINICAL SERVICES 2. EDUCATION AND SUPPORT 3. ACCESS TO SERVICES/RESOURCES 4. SPONSORSHIPS CATEGORIES 1 AND 2 DRAW ON MEEI'S BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES. CATEGORY 4 REPRESENTS MEEI'S OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MEEI AND WHO ARE PROVIDING SERVICES TO MEEI'S PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERAL'S COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR FOR EACH STRATEGY IN THE CATEGORY. FISCAL YEAR 2013 WAS YEAR TWO OF MEEI'S THREE-YEAR PLAN. CATEGORY 1: SCREENING & CLINICAL SERVICES MEEI PROVIDES SCREENING AND CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF DOMESTIC VIOLENCE. SPECIFIC INITIATIVES ARE AS DESCRIBED BELOW: NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS) NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MEEI'S DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNERED WITH NHCS'S SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MEEI. WORKING WITH NHCS' SCHOOL NURSE, MARY MCNULTY-ANGLIN, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE. CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTON'S AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MEEI'S EXPERTISE IN VISION SCREENING, MAYOR MENINO REQUESTED THAT MEEI PLAY A ROLE AT CAMP HARBOR VIEW. MEEI HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MEEI STAFF MEMBERS TRAVELED TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MEEI PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MEEI STAFF MEMBERS GIVE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. HEAD AND NECK CANCER SCREENING/LECTURE: MEEI'S DEPARTMENTS OF ENT AND SOCIAL WORK COLLABORATE TO OFFER CANCER SCREENING TO THE GENERAL PUBLIC AND TO PROVIDE SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER. SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER HAS A SUPPORT GROUP CHAPTER AT MASSACHUSETTS GENERAL HOSPITAL. MEEI COLLABORATES WITH THIS GROUP AND WITH THE HEAD AND NECK CANCER ALLIANCE TO RAISE AWARENESS DURING ORAL, HEAD AND NECK CANCER AWARENESS WEEK BY HOSTING AN EDUCATION TABLE. R.O.S.E. FUND COLLABORATION: THE R.O.S.E. FUND (REGAINING ONE'S SELF ESTEEM) IS A NON-PROFIT ORGANIZATION CHARTERED TO BREAK THE SILENCE AND THE CYCLE OF DOMESTIC VIOLENCE AND TEEN DATING VIOLENCE AND ABUSE. AMONG ITS MANY ACTIVITIES, THE R.O.S.E. FUND SCREENS AND REFERS TO MEEI SURVIVORS OF DOMESTIC VIOLENCE IN NEED OF RECONSTRUCTIVE SURGERY. MEEI'S SURGEONS PERFORM THESE LIFE-ALTERING SURGERIES FREE OF CHARGE. The Legacy Project: The Legacy Project is a grassroots effort to provide support to seniors who reside in Mission Hill. Leaders of the Legacy Project reach out to seniors living in both public housing developments and to those who are living alone, providing information about services and community events. The Legacy Project also hosts a range of educational sessions and activities in its space at the Tobin Community Center. Activities range from computer classes to exercise and dance to intergenerational forums. The Legacy Project aims to build community through inclusiveness and communication, and partners with Mass. Eye and Ear in its community benefit programming for seniors. CATEGORY 2: EDUCATION & SUPPORT MEEI'S CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS) AND ALSO REACH OUT TO PROVIDERS WHO INTERACT WITH SENIORS ACROSS THE COMMONWEALTH. DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW: PUBLIC FORUM ON HEARING AND HEARING LOSS: MEMBERS OF MEEI'S AUDIOLOGY DEPARTMENT PRESENTED AN 11TH ANNIVERSARY HAVE YOU HEARD? PUBLIC FORUM FEATURING EDUCATIONAL SESSIONS AND LECTURES ON HEARING AND HEARING LOSS. THIS YEAR'S SESSIONS FOCUSED ON THE MEDICAL AND SURGICAL MANAGEMENT OF HEARING LOSS, AUDIOLOGIC EVALUATION AND MANAGEMENT OF HEARING LOSS, AND SCIENTIFIC ADVANCES IN UNDERSTANDING HEARING AND HEARING LOSS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS AND INDIVIDUALS WITH HEARING LOSS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND THROUGH MEEI PARTNERSHIP WITH THE MASSACHUSETTS COUNCIL ON AGING. MEEI SURVEYS FORUM PARTICIPANTS AND WILL USE THEIR SUGGESTIONS TO DEVELOP THE EDUCATIONAL PROGRAM FOR NEXT YEAR. PUBLIC FORUM ON CONDITIONS THAT AFFECT SMELL AND TASTE: THIS YEAR, MEMBERS OF MEEI'S DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON SINUSITIS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND VIA MEEI'S PARTNERSHIP WITH THE MASSACHUSETTS COMMISSION ON AGING. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MEEI HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. THE BOSTON CURED CANCER GROUP COMES AND MEETS WITH NEW LARYNGECTOMEES, PROVIDING SUPPORT TO MEEI PATIENTS. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF IMAGE. MEEI HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MEEI PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. GLAUCOMA SUPPORT GROUP: THE GLAUCOMA FOUNDATION FUNDS GROUNDBREAKING RESEARCH AND EDUCATES THE PUBLIC ABOUT GLAUCOMA AND THE IMPORTANCE OF EARLY DETECTION TO PREVENT BLINDNESS. THE NEW ENGLAND CHAPTER OF THE GLAUCOMA FOUNDATION HOSTS A SUPPORT GROUP FOR PEOPLE WITH GLAUCOMA, THEIR CAREGIVERS, PROFESSIONALS, AND OTHERS DEDICATED TO IMPROVING THE LIVES OF THOSE WITH THIS DISEASE. MEEI PARTNERS WITH THE GLAUCOMA FOUNDATION TO PROVIDE FREE MEETING SPACE AND PUBLICITY. MEMBERS OF MEEI'S DEPARTMENT OF OPHTHALMOLOGY ARE AVAILABLE AS SPEAKERS FOR THE GROUP. MEEI HELPS PROMOTE THE GROUP BY DISTRIBUTING FLYERS IN THE HOSPITAL'S CLINICS. ATTENDEES ARE GENERALLY SENIORS FROM METRO BOSTON. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MEEI DONATES MONTHLY MEETING SPACE AND MEEI CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTON'S MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. Mission Hill Community Health Fair: Mass. Eye and Ear, Longwood, was out in full force at the Mission Hill Community Health Fair, an annual wellness event. Mass. Eye and Ear provided safety tips for hearing and vision protection and learned about disease prevention. THYROID EYE DISEASE SUPPORT GROUP: THE MASSACHUSETTS EYE AND EAR INFIRMARY OFFERS A THYROID EYE DISEASE (GRAVES' DISEASE) SUPPORT GROUP, WHICH WILL ALLOW MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES' DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MEEI DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MEEI STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION. DRESS FOR SUCCESS: THE MISSION OF DRESS FOR SUCCESS BOSTON IS TO PROMOTE THE ECONOMIC INDEPENDENCE OF DISADVANTAGED WOMEN. THEY DO THIS BY PROVIDING PROFESSIONAL ATTIRE, A NETWORK OF SUPPORT AND THE CAREER DEVELOPMENT TOOLS TO HELP WOMEN THRIVE IN WORK AND IN LIFE. MEEI MAKES AN ANNUAL DONATION TO THIS ORGANIZATION TO HELP ADVANCE ITS EFFORTS IN WORKFORCE DEVELOPMENT AMONG LOW-INCOME WOMEN. 1 TOUCH: MEEI PROVIDES FACILITIES AND SUPPORT FOR THIS ORGANIZATION'S SPECIAL SELF-DEFENSE GROUP THAT ENABLES THE BLIND AND VISUALLY IMPAIRED TO DEFEND THEMSELVES AND NAVIGATE THE WORLD WITH CONFIDENCE. Internships/Coops: Mass. Eye and Ear provides internships and coops to help get young people interested in health care so they can better care for their communities. Partners include the PIC program, John Hancock, YMCA Training, Inc, Northeastern University. The Tobin Community Center: The Tobin Community Center is one of 35 Boston Center for Youth and Families facilities which are located in every neighborhood in Boston. The Center provides recreational space and activities for youth and families, including basketball courts, workout space, a daycare facility, career learning center and a diverse range of programs and activities for all interests. The mission of BCYF is to enhance the quality of life for Boston's residents by supporting children, youth and families through a wide range of programs and services. The Center hosts Mass. Eye and Ear educational sessions. Mission Hill Youth Collaborative: The Mission Hill Youth Collaborative is a grassroots coalition of community-based organizations and institutions that promotes the well-being of the neighborhood's young people and their families through collaborative activities. MHYC brings together youth-serving organizations and institutions to address the needs of the community in light of changing economic and social conditions as well as institutional expansion. The members have advocated for more effective programming, improved resources, and built a support network for the Mission Hill youth workers, youth, and their families. John Hancock MLK Summer Scholars: The MLK Summer Scholars program addresses a critical need in the City of Boston - summer jobs for youth. Mass. Eye and Ear hires young people each summer. In additional to the experience gained on the job, interns get additional support through participation in weekly job readiness and life skills workshops. Mass. Eye and Ear provides a summer job to one MLK Scholar each summer. Boston Private Industry Council (PIC): The PIC is a public-private partnership that connects business, schools, government, labor, and community organizations to create innovative workforce solutions. PIC helps businesses develop the workforce they need and Boston residents gain access to career opportunities and higher incomes. The PIC connects youth and adults with education and employment opportunities. Mass. Eye and Ear hires 12 PIC students as summer interns. CATEGORY 3: ACCESS TO SERVICES/RESOURCES THIS CATEGORY DESCRIBES MEEI STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. THESE SERVICES AND RESOURCES ARE AS FOLLOWS: TRANSPORTATION FOR NEEDY PATIENTS: MEEI PROVIDES FREE TAXI TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MEEI PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MEEI PATIENTS: MEEI'S SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MEEI PATIENTS. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MEEI'S DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MEEI. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITAL'S FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MEEI'S RESEARCH LIBRARY STAFF ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MEEI HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION AND EQUIPMENT, TO PATIENTS WITH HEARING LOSS. FOR PATIENTS WHO MEET INCOME GUIDELINES, THESE SERVICES ARE PROVIDED AT NO CHARGE OR AT A REDUCED RATE. FREE PARKING: MEEI OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MEEI ALSO EXTENDS FREE PARKING TO PARTICIPANTS AT COMMUNITY BOATING, A LOCAL NONPROFIT, AND TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. CHARITABLE CARE: EACH YEAR, MEEI PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS YEAR THE HOSPITAL PROVIDED $198,116 IN FREE OR DISCOUNTED CARE TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. MEEI MAKES EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MEEI PROVIDES CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2013, MEEI'S NET CHAIRTY CARE TOTALLED $2,412,274, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MEEI'S AND THE COMMUNITY BENEFITS COMMITTEE'S COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN THE MEEI COMMUNITY BENEFITS PLAN. CATEGORY 4: SPONSORSHIPS MEEI DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT IN THE FORM OF SPONSORSHIPS TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THOSE OF MEEI AND ITS COMMUNITY BENEFITS GOALS, INCLUDING THOSE WHO ADDRESS ISSUES AFFECTED THE TARGET COMMUNITIES AND POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH. SCHEDULE H, PART VI, LINE 7: LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA true BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVE BOSTON MA 02115 042774441 501(C)(3) 213066 RESEARCH BOSTON UNIVERSITY 85 E NEWTON ST M-921 BOSTON MA 02118 042103547 501(C)(3) 191201 RESEARCH BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 464633 RESEARCH OHIO UNIVERSITY 1 PARK PLACE ATHENS OH 45701 316402113 501(C)(3) 16641 RESEARCH MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST BOSTON MA 02114 042697983 501(C)(3) 590145 RESEARCH MIT DIVISION OF HEALTH 77 MASS AVE CAMBRIDGE MA 02139 042103594 501(C)(3) 183813 RESEARCH MAYO CLINIC 200 1ST ST SW ROCHESTER MN 55905 416011702 501(C)(3) 69764 RESEARCH HARVARD UNIVERSITY MASS HALL CAMBRIDGE MA 02138 042103580 501(C)(3) 801506 RESEARCH UNIVERISITY OF SOUTHERN CALIFORNIA 3720 S FLOWER ST LOS ANGELES CA 90089 951642394 501(C)(3) 53207 RESEARCH VANDERBILT MEDICAL CENTER 211 KIRKLAND HALL NASHVILLE TN 37240 620476822 501(C)(3) 138101 RESEARCH WORCESTER POLYTECHNIC INSTITUTE 100 INSTITUTE RD WORCESTER MA 01609 042121659 501(C)(3) 282544 RESEARCH SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON MA 02114 042129889 501(C)(3) 1725410 RESEARCH UNIVERSITY OF MIAMI 1400 NW 10TH AVE MIAMI FL 33136 590624458 501(C)(3) 126374 RESEARCH UNIVERSITY OF MISSISSIPPI 2500 N STATE ST JACKSON MS 392164505 646001159 501(C)(3) 100154 RESEARCH BROAD INSTITUTE 7 CAMBRIDGE CENTER CAMBRIDGE MA 02142 263428781 501(C)(3) 145515 RESEARCH MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RD MILWAUKEE WI 53226 390806261 501(C)(3) 58768 RESEARCH CARES 5000 S 5TH AVE HINES IL 60141 363334177 501(C)(3) 170852 RESEARCH DREXEL UNIVERSITY 3201 ARCH ST 100 PHILADELPHIA PA 19104 231352630 501(C)(3) 85105 RESEARCH LAWRENCE LIVERMORE NATIONAL SECURITY LLC MS L 397 7000 E AVE LIVERMORE CA 94550 205624386 OTHER 10798 RESEARCH MASSACHUSETTS EYE AND EAR ASSOCIATES INC 243 CHARLES STREET BOSTON MA 02114 222658209 501(C)(3) 9966948 INSTITUTIONAL RHODE ISLAND HOSPITAL 593 Eddy Street Providence RI 029034923 050258954 501(c)(3) 237616 RESEARCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SD 9500 Gilman Dr MC0934 San Diego CA 92023 956006144 501(c)(3) 36828 RESEARCH JOAN&SANFORD IWEILL MEDICAL COLL OF CORNEL UNIV 1305 New York Ave New York NY 10065 150532082 501(c)(3) 100016 RESEARCH MARSHFIELD CLINICAL RESEARCH FOUNDATION 1000 North Oak Avenue Marshfield WI 54449 390452970 501(c)(3) 48625 RESEARCH CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE 10900 Euclid Ave Cleveland OH 441067015 341018992 501(c)(3) 72220 RESEARCH BOSTON MEDICAL CENTER 660 Harrison Ave 2nd Floor Boston MA 021182393 043314093 501(c)(3) 36102 RESEARCH UNIVERSITY OF WASHINGTON 1730 Minor Ave STE 1360 Seattle WA 98101 916001537 501(c)(3) 29806 RESEARCH SCHEPENS EYE RESEARCH INSTITUTE 20 STANIFORD ST BOSTON MA 02114 042129889 501(C)(3) 570606 INSTITUTIONAL 27 1 SCHEDULE I, PART I, LINE 2: SUBAWARDS ARE ISSUED THROUGH A CONSORTIUM AGREEMENT BETWEEN THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") AND THE RECIPIENT INSTITUTION. THE AGREEMENT SPECIFIES THE TERMS OF THE SUBAWARD AND INCLUDES A DETAILED BUDGET AND SCOPE OF WORK TO BE PERFORMED BY THE RECIPIENT INSTITUTION. AWARDED FUNDS ARE ENCUMBERED BY A PURCHASE ORDER THAT IS ASSIGNED TO A UNIQUE FUND NUMBER. PAYMENTS TO RECIPIENT INSTITUTIONS MADE AGAINST THE PURCHASE ORDER ARE RECORDED IN THE MEEI ACCOUNTING SYSTEM SO THAT INDIVIDUAL PAYMENTS AND PURCHASE ORDERS BALANCES CAN BE MONITORED. DISBURSEMENT OF FUNDS FOR SUBAWARDS REQUIRES THE WRITTEN APPROVAL OF THE PRINCIPAL INVESTIGATOR ("PI"). FREQUENT PROGRESS REPORTS AND OTHER FORMS OF COMMUNICATION ARE REQUIRED BETWEEN THE PI AND THE SUBAWARD RECIPIENT INSTITUTE TO ENSURE THAT THE SCOPE OF WORK IS PROGRESSING AT A SATISFACTORY PACE. X X X X true true false false false false false true false JOHN R FERNANDEZ 640224 0 169660 0 810 0 132843 0 22198 0 965735 0 0 0 JOAN W MILLER MD 0 677686 0 85486 0 17833 0 34495 0 21811 0 837311 0 0 JOSEPH B NADOL JR MD 0 685358 0 70882 0 25933 0 34495 0 28259 0 844927 0 0 SUSAN WILLIAMS 225529 0 25509 0 17574 0 10660 0 8404 0 287676 0 0 0 MAUREEN KELLEY 168771 0 3250 0 362 0 6857 0 21405 0 200645 0 0 0 CAROLANN WILLIAMS 286775 0 73660 0 408 0 9982 0 1520 0 372345 0 0 0 BARBARA J SCULLY 164713 0 5000 0 216 0 13123 0 21336 0 204388 0 0 0 EILEEN O LOWELL 213674 0 26744 0 894 0 12300 0 21611 0 275223 0 0 0 ALAN K LONG 184720 0 18768 0 18220 0 7541 0 1006 0 230255 0 0 0 CHRISTINE REGAN 212782 0 22758 0 2209 0 14039 0 21336 0 273124 0 0 0 KENNETH HOLMES 222140 0 55150 0 17813 0 6857 0 21762 0 323722 0 0 0 JEAN E MACQUIDDY 231436 0 16059 0 2754 0 24781 0 9061 0 284091 0 0 0 JEFFREY J PIKE 273668 0 72376 0 427 0 10372 0 8571 0 365414 0 0 0 JAVIER BALLOFFET 225600 0 68339 0 19415 0 14617 0 21788 0 349759 0 0 0 JENNIFER STREET 266009 0 72514 0 643 0 11010 0 21990 0 372166 0 0 0 MELISSA M PAUL 200784 0 22548 0 6163 0 14440 0 21695 0 265630 0 0 0 GLENN W BUNTING 175948 0 1500 0 667 0 14482 0 23728 0 216325 0 0 0 GREGORY J DONNELLY 167657 0 8755 0 148 0 9468 0 21129 0 207157 0 0 0 PETER J CHINETTI 0 0 0 0 110893 0 0 0 225 0 111118 0 0 0 PHILLIP C JOHNSON 161964 0 10000 0 17658 0 18137 0 21382 0 229141 0 0 0 RALPH T PELOSI 163958 0 8498 0 1472 0 6268 0 208 0 180404 0 0 0 ALEC CHELOFF 132958 0 0 0 54245 0 3460 0 16168 0 206831 0 0 0 SCHEDULE J, PART I, LINE 4A: In connection with his departure effective May 1, 2011, Peter Chinetti received 12 months of Salary and Benefit continuation. In connection with his departure effective June 30, 2012, Alec Cheloff received 4 months of Salary and Benefit continuation. SCHEDULE J, PART I, LINE 4B: John Fernandez participates in a Deferred Compensation arrangement with Massachusetts Eye and Ear. Under this agreement, Mr. Fernandez will be credited $120,000 for CALENDAR YEAR 2012. Each annual credit will vest on the fourth anniversary of the date such credit was made or upon (1) the attainment of the age of 65 while employed; (2) termination without cause or resignation for good reason; (3) death; (4) disability; or (5) change of control of MASSACHUSETTS Eye and Ear within the meaning of section 409A of the Internal Revenue Code. SCHEDULE J, PART I, LINE 7: The Board of Trustees of the Massachusetts Eye and Ear Infirmary, upon recommendations of the Compensation Committee, approve a bonus program for certain individuals listed on the Schedule J. The program requires that supervisory personnel make the determination of (1) eligibility and (2) amount of bonus dollars based on overall job performance. The CEO of the Infirmary has the authority to (1) overrule recommendations made by supervisors and (2) make bonus determinations for Vice President level personnel. The Compensation Committee of the board has the final authority for bonuses paid to the CEO as well as the Vice Presidents. Total Compensation for listed individuals, including bonus payments, was analyzed by independent compensation consultants, determined to be reasonable compensation, and approved by the Board. No compensation payment can be made in excess of these amounts. A MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES 042456011 57586EWL1 2010-09-29 63156092 FACILITY IMPROVEMENTS false false false B MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES 042456011 57586ELD1 2007-03-22 20000000 FACILITY IMPROVEMENTS false false true C MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES 042456011 57586ELD1 2005-02-25 13695000 FACILITY IMPROVEMENTS false false true A 0 0 63156092 4993936 5191181 0 1360310 0 0 42858859 0 8751806 false false false true B 7815000 0 20000000 121854 0 0 108810 0 0 19769336 0 0 2010 false false true true C 5902139 0 13695000 77930 0 0 71758 0 0 13545312 0 0 2009 false false true true A false false false false 0 false true B false false false false 0 false true C false false false false 0 false true A false true false false 0 false 0 false false B true true false 0 false 0 false C true true false 0 false 0 false false A true B true C true PART I, BOND (A), COLUMN (F): 0 THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS. PART I, BOND (B), COLUMN (F): 0 THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. PART I, BOND (C), COLUMN (F): 0 THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. KENNETH HOLMES HOUSING X 50000 10000 false false true 10000 JOAN MILLER MD DRCTR IS LICENSOR TO ORG 244124 PATENT LICENSE PROCEEDS false SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS (A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY. FORM 990, PART I, LINE 1 & PART III, LINE 1: THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI"). FORM 990, PART III, LINE 4A: RESEARCH Ophthalmology: - A New, Complete Catalogue: Gene Expression in the Human Retina Published. Michael Farkas, PhD, Eric Pierce, MD, PhD, and investigators in the HMS Ophthalmology Ocular Genomics Institute (OGI) at Mass. Eye and Ear recently published the most thorough description of gene expression in the human retina (BMC Genomics, July 2013). According to researchers, documenting the entirety of these genetic data into a catalogue is crucial for understanding how diseases of the eye develop and lead to vision loss. Investigators used a technique called RNA sequencing (RNA-seq) to identify all of the messenger RNAs (mRNAs) produced in the human retina. This catalog of expressed genes, or transcriptome, revealed that the majority of the 20,000+ genes in the human body are expressed in the retina. The researchers also identified almost 30,000 novel exons (portions of the genome that are used to encode proteins or other genetic elements) and over 100 potential novel genes that had not been identified previously. To date, investigators have identified more than 200 retinal degeneration disease genes, but identification of new exons used in the retina may help find the cause of disease in currently undiagnosed patients. - First Corneal Transplant Performed With Pre-loaded Tissue. Roberto Pineda, II, MD performed a series of groundbreaking procedures in April 2013 when he utilized EndoGlide (Angiotech Pharmaceuticals, Inc.) cartridges pre-loaded at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL for endothelial keratoplasty transplant procedures at the Mass. Eye and Ear. Dr. Pineda utilized donor endothelial tissue that was pre-cut, trephined and pre-loaded into the devices before being sent to the Mass. Eye and Ear for transplantation. In 2012, the LEITR presented a pre-clinical study at the 2012 ARVO Annual Meeting reporting that eye banks are able to safely prepare and load corneal tissue into the EndoGlide cartridges. - Mass. Eye and Ear Joins Global Alliance to Share Genomic and Clinical Data. Massachusetts Eye and Ear is among the nearly 70 leading health care, research, and disease advocacy organizations that have joined together to form an international alliance dedicated to enabling secure sharing of genomic and clinical data. The alliance will support the formation of large, shared datasets that will allow researchers around the globe to identify target pathways and develop transformational therapies for patients. The group will develop methods and policies to share information responsibly, while protecting patient privacy and the public interest. Research Successes: - 238 Proposals - 88 Awards - Total grants awarded: $32,740,597 Retina: - Members of the Angiogenesis Laboratory investigated the mechanism of cell death in retinal degenerations and showed that RIP Kinase mediated programmed necrosis, not apoptosis, is a key mediator of photoreceptor cell loss and damage associated molecular pattern mediated inflammation in animal models of inherited retinal degenerations (IRD) and dry AMD. This can lead to novel therapeutics for dry AMD, IRD, and other retinal disorders. - Researchers from the Angiogenesis Laboratory examined the role of the energy sensor for the cell called AMPK and showed it to regulate vascular cell permeability and angiogenesis. This can lead to a new class of anti-leakage and anti-angiogenesis drugs. - Studied non-chemotherapy drugs for retinoblastoma and showed the role of a small activator of the metabolic and energy sensor AMPK in inhibiting retinoblastoma cell growth in vivo in an animal model. This could lead to gentler therapies for children with retinoblastoma. - Conducted clinicopathologic and immunohistochemical studies of conjunctival large cell acanthoma, epidermoid dysplasia, and squamous papilloma. Showed that conjunctival large cell acanthoma is a morphologically distinctive clonal entity with clinical and immunohistochemical phenotypic characteristics denoting a dysplasia of minimal severity. Because of recurrences without invasion, it requires treatment. - Presented an improved technique of experimental retinal detachment in rodents that result in more reproducible results. - Showed that a simple non-invasive test can be used to monitor a rare inflammatory disease of the retina called ampiginous choroiditis. - Presented a comprehensive review on photoreceptor cell death pathways and neuroprotection strategies in Progress in Retina Eye Research. - Was a participating center in the Age-Related Eye Disease Study 2 (AREDS2), a large multicenter clinical trial funded by the National Eye Institute, which clarified the effectiveness of specific dietary supplement formulations for the treatment of AMD. - Provided pre-clinical evidence that ranibizumab, a vascular endothelial growth factor inhibitor, may prevent vitreoretinopathy (PVR), a serious complication that can occur after surgical repair of retinal detachment. - Demonstrated that converting patients with chronic neovascular AMD to aflibercept (Eylea) results in stabilized vision and improved anatomic outcomes, while allowing injection intervals to be extended. - Showed that CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. - Demonstrated that AMD-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1. Ocular Genomics Institute (OGI): - Inherited macular degeneration: In a study published in the journal Human Molecular Genetics, members of the OGI reported for the first time that that the complement system plays a critical role in the early stage of an inherited macular degeneration, in addition to being associated with age-related macular degeneration. This is important because it provides insight into how alterations in complement system components contribute to macular disease. - Human retinal transcriptome: Researchers from the group reported the most thorough description of gene expression in the human retina reported to date. In the study published in the journal BMC Genomics, Drs. Michael Farkas, Eric Pierce and colleagues in the Ocular Genomics Institute at Mass. Eye and Ear reported a complete catalog of the genes expressed in the retina. This is a valuable resource for the vision research community, and the data are available via the OGI website (see http://oculargenomics.meei.harvard.edu/index.php/ret-trans). - Reported that the adeno-associated virus AAV9 selectively targets cone photoreceptors in the non-human primate. - Milestones from the OGI include: Genomics core facility open, and providing research genomics services as well as CLIA-certified genetic diagonstic testing (information available via OGI website; see http://oculargenomics.meei.harvard.edu/index.php/gc and http://oculargenomics.meei.harvard.edu/index.php/gdt, respectively). - Recruited Dr. Xiaowu Gai to lead the Bioinformatics program of the OGI, and establish a Bioinformatics Shared Resource for the Department. Dr. Gai is a talented informaticist, and is currently Director of Biomedical Informatics, Loyola University Chicago Stritch School of Medicine. - The first OGI course "Genetics and genomics of ocular disease," directed by Dr. Janey Wiggs was presented as a satellite meeting of the American Society of Human Genetics. - Berman Gund Laboratory for the Study of Retinal Degenerations - Used whole-genome sequencing to identify pathogenic DNA structural changes and a new disease gene for retinitis pigmentosa. Cornea: - Completed a clinical study evaluating the efficacy of a topical combined anti-PDGF and anti-VEGF therapy in corneal angiogenesis. - Created and validated an ocular redness continuous (0.0 - 100.0) scale using a novel, state-of-the-art computer program. - Completed a study assessing the use of tear osmolarity as a new method to diagnose and monitor dry eye disease. - Developed telomerase-immortalized corneal endothelial cell line which will provide a new tool for the in vitro study of corneal endothelial cell biology and will be made available to the NIH community. - Determined that deficiency in Nrf2-regulated pathway is involved in the pathogenesis of Fuchs endothelial corneal dystrophy. - Determined that corneal limbal fibroblasts can be differentiated into corneal epithelial cells thus serving as a novel source of corneal epithelium usually destroyed in limbal stem cell deficiency disorders. - Demonstrated the presence of the integrin MadCAM-1 in the ocular surface vasculature and determined its role in the recruitment of corneal immune cells. - First human implantation of an intraocular device to measure IOP by telemetry. This may resolve the inability to measure IOP in keratoprosthesis patients. - Conducted the first large scale cataract surgery outcomes review (18,000 cases) in the UK independent sector (private-sector owned treatment centers contracted within the English National Health Service to treat NHS patients free at the point of use). - Demonstrated with live corneal imaging that unilateral corneal infections, including in herpes zoster ophthalmicus, lead to contralateral changes in corneal nerves in the unaffected eye, suggesting neuro-regulatory mechanisms between eyes. - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month. - Determined that devices used in PROSE treatment can be customized to accommodate any eye with keratoconus or post-LASIK ectasia regardless of disease severity. - Performed first collagen cross-linking in Boston, an experimental treatment for keratoconus, under the auspices of an FDA-sanctioned clinical trial. - Completed a study on worldwide incidence of infections after keratoprosthesis, and evaluation of optimal antibiotics prophylaxis. - Determined risk of light damage to retina during keratoprosthesis surgery. - Received FDA approval for the use of titanium in keratoprosthesis. - Quantified the risk of glaucoma after keratoprosthesis. - Constructed a new glaucoma valve. - Demonstrated radical reduction of complications by using oversized back plates in keratoprosthesis. - Published the largest ever series of pediatric herpes simplex. Demonstrated use of acyclovir in children and recommended treatment and maintenance doses (Liu et al, Ophthalmology 2012). - Demonstrated oversized backplates for KPro associated with better wound anatomy to try to reduce RPM formation (Cruzat et al, Cornea 2013) - MEEI will be a premier site for the upcoming Zoster Eye Disease Study (ZEDS), which will evaluate the effect of long-term systemic antiviral of the ophthalmic complications of shingles. Drs Colby and Langston will serve on the Executive Committee for this study. - Completed and have in press in Cornea clinical study showing that ganciclovir gel (Zirgan) is rapidly effective in healing Herpes zoster pseudodendritic ulcers of the cornea. - Completed clinical study "Patients with Infectious Keratitis Demonstrate Persistent and Long-term Increase in Immune cells and Diminished Subbasal Corneal Nerves After Cessation of Anti-Microbial Therapy -- A Laser in vivo Confocal Microscopy Study." - Demonstrated that a drug-eluting contact lens can deliver a therapeutic amount of a glaucoma medication for one month, published in Biomaterials. - Reported the findings from a large, multi-center study that found that excellent retention of the Type I Boston Kpro - 93% of the 300 Kpro implants were retained at their last follow-up, corresponding to a retention time of 396 patient-years or 1.42 years/keratoprosthesis in Ophthalmology. - Validated measurement of corneal dendritiform cells by in vivo confocal microscopy as a measure to assess ocular surface inflammation - Completed large multi-center clinical trial, demonstrating that combination of contact lenses and contact lens solutions are more important that each factor alone in inducing ocular surface inflammation - Launched grant from the Department of Defense to conduct a multi-center clinical trial to assess the safety and efficacy of an anti-VEGF in patients who are at high-risk for graft rejection following their corneal transplant. - Completed several clinical studies demonstrating that the use of autologous serum tears result in corneal nerve regeneration and in reversal of symptoms of corneal neuralgia and light sensitivity in patients with corneal neuropathies. - Completed a study evaluating the efficacy of a steroid vs. a steroid and antibiotic in patients with ocular inflammation related to dry eye disease - Reported on patients with bilateral corneal ulceration in ocular graft-versus-host disease. - Created novel software programs to quantify ocular surface staining and ocular redness, methodologies which will allow for more accurate measurements of ocular disease and progression. - Generated a large database on patients with ocular graft-versus-host disease. - Developed a surgical safety checklist for refractive procedures in association with the Institute for Safety in Office-based Surgery (ISOBS). - Published a novel method for cross linking ectatic corneas. Glaucoma: - Contributed to an international effort reporting on 27 genetic loci that explain variance in central corneal thickness. Six of these loci are also associated with keratoconus and 1 represented a new locus for primary open-angle glaucoma. This work was published in Nature Genetics. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, glaucoma investigators used a case-only approach to demonstrate that genetic loci in the CDKN2B-AS1 region alter optic nerve vulnerability to glaucomatous damage. - Demonstrated an inverse relation between serum TNF receptor 2 levels and incident normal tension glaucoma among women. This study is based on a case control group nested within a population-based study (the Nurses Health Study) and serum samples on cases were collected prior to when glaucoma treatment was instituted. To the best of our knowledge, this is the first demonstration of a serum biomarker that is associated with a reduced risk of open-angle glaucoma. - Described the results of a randomized trial comparing the impact of fixed combination timolol-dorzolamide to fixed combination timolol-brimonidine in the co-regulation of retinal blood flow and ocular perfusion pressure. - Dr. Emmanuel Buys (MGH) and several members of the Harvard Glaucoma Center of Excellence, described a murine model of open angle glaucoma that is based on knocking out the intracellular receptor for nitric oxide, soluble guanylate cyclase. These mice develop modest, age-related increases in IOP and optic nerve degeneration that mimics the normal tension variant of primary open-angle glaucoma. More significantly, Dr. Buys and co-workers demonstrated that a common variant in the gene region for soluble guanylate cyclase is associated with primary open angle glaucoma that presents with paracentral visual loss. - Led an effort to demonstrate that several of the prostaglandin analogues in current use to treat glaucoma are strongly associated with atrophy of the periorbital fat, upper eyelid ptosis and loss of low eyelid steatoblepharon. - On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, investigators evaluated the collective relation between common genetic polymorphisms involved in estrogen metabolism and primary open-angle glaucoma. The work demonstrates that this panel of estrogen metabolizing polymorphisms is associated with primary open glaucoma in women but not in men. - Confirmed that TMCO1 loci are associated with intraocular pressure in conjunction with the GLAUGEN (Glaucoma Genes and Environment) study, the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, and the Age-related Macular Degeneration- Michigan, Mayo, AREDS and Pennsylvania study investigators. - Contributed to the International Consortium of African Ancestry Research in Glaucoma and demonstrated that genetic loci in the CDKN2B-AS1 region are associated with primary-open angle glaucoma among African Americans but not among African people derived from Ghana. OTOLARYNGOLOGY: - Benjamin Bleier, M.D., Nicolas Busaba, M.D., Stacey Gray, M.D., and Eric Holbrook, M.D., have co-authored a study on the effectiveness of different treatments of nosebleeds for adults. The study, published in Otolaryngology-Head and Neck Surgery, found that in a limited observation, surgical and/or medical intervention offered the best outcome in adults with nosebleeds. - Albert Edge, Ph.D., is the lead author of a study conducted with hearing researchers at Massachusetts Eye and Ear Infirmary and Harvard Medical School who have, for the first time, regenerated sensory hair cells in the ear, resulting in restored hearing to noise-damaged ears. The Jan. 10, 2013 issue of Neuron features the research study, as well as a video discussion with Dr. Edge. - In a May 2013 issue of Cancer, investigators at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary, including Edmund Mroz, Ph.D., Aaron Tward, M.D., Ph.D., and James Rocco, M.D., Ph.D., describe how their measure of heterogeneity of cells within a tumor appears to predict treatment outcomes of patients and was a better predictor of survival than most traditional risk factors in a small group of patients with squamous cell carcinoma, the most common type of head and neck cancer. - In a March issue of the Journal of Neuroscience, researchers found that noise exposure is clearly more dangerous than typically thought and gained insight into why it is difficult for some people to hear in "everyday" noisy environments. Stephane Maison, Ph.D. and M. Charles Liberman, Ph.D., were lead authors on this publication. - Led by Daniel Lee, M.D., researchers from the Wilson Auditory Brainstem Implant Program at Massachusetts Eye and Ear are currently conducting the only FDA-approved clinical trial in the U.S. for adult deaf patients who do not have NF2 to receive the ABI. The study was given clearance by the Human Studies Committees of Mass. Eye and Ear and Harvard Medical School in November 2012. A second study for pediatric patients who are deaf but do no have NF2 to receive the ABI was FDA-approved in May 2013. Radiology: - Renee Mitchell, Lead CT/XRAY radiologic technologist, performed high resolution cadaveric sinus scans for Dr. Benjamin Bleier for image guidance during the resident sinus dissection courses. - Renee Mitchell worked with Dr. Yoojin Chung and Jennifer O'Malley on a study with Dr. Bertrand Delgutte who is the principal investigator of these studies, where cochlear implanted rabbits are part of projects investigating neural responses to electrical stimulation and brain plasticity in animal models of human cochlear implants at the Eaton-Peabody Lab. The imaging scans are to ascertain the proper positioning of the CI's in these animals. FORM 990, PART III, LINE 4B: EDUCATION ACADEMIC PROGRAMS: OTOLARYNGOLOGY: - 18 RESIDENTS - 11 CLINICAL FELLOWS - 49 RESEARCH FELLOWS - 2 RESEARCH RESIDENTS OPHTHALMOLOGY: - 23 RESIDENTS - 26 CLINICAL FELLOWS - 102 RESEARCH FELLOWS Ophthalmology: - International Collaborations. The Department continues to build upon existing relationships that HMS Ophthalmology faculty and Chinese colleagues have been cultivating for several years. Faculty from Mass. Eye and Ear and Schepens traveled to China in a series of visits this year to exchange perspectives on research efforts and clinical care and management practices. One key mission of the trip was to strategically and cooperatively identify training opportunities as part of the Department's new International Research & Training program, which is now working smoothly to place trainees in department laboratories. Faculty from Eye and ENT Hospital of Fudan University visited in June for the Annual & Alumni Department meeting and a series of discussions. - Dong Feng Chen, MD, PhD Chair of Women's Eye Health.org is collaborating with associates from Peking University First Hospital to produce an educational TV series about eye disease for Beijing TV. The series complements the organization's worldwide outreach efforts to build awareness of the prevalence of eye disease in women. - The new Office of Global Surgery and Health established at Mass. Eye and Ear partners with training hospitals in underserved countries to improve residency programs in ophthalmology through onsite surgical instruction, remote education innovation and opportunities for research collaboration. - Inaugural HMS Ophthalmology Faculty Retreat. More than 100 Harvard Medical School (HMS) Department of Ophthalmology faculty members joined together for a two-day retreat at Wentworth by the Sea in Newcastle, NH on April 5-6, 2013. The inaugural event united clinicians and scientists from across the department and presented a forum for candid discussion, dialogue and exchange that aimed to coalesce translational efforts and more rapidly advance bench to bedside discovery. The retreat also provided a relaxed and casual "meet-and-greet" venue for faculty. Topics of discussion included overviews of the Department's growing Centers of Excellence and Institutes, expanded international collaborations, strengthened department-industry partnerships, and faculty development efforts. - Faculty Promotions and Appointments: HMS Appointments: - Endowed Professorships: - Patricia D'Amore, PhD, MBA, FARVO, The Charles L. Schepens Professor of Ophthalmology - Dean Eliott, MD, Stelios Evangelos Gragoudas Associate Professor of Ophthalmology - Professor of Ophthalmology: - Darlene Dartt, PhD, FARVO, Schepens/Mass. Eye and Ear - Associate Professor of Ophthalmology: - Don Bienfang, MD, Brigham and Women's Hospital - Assistant Professor of Ophthalmology: - Joseph Ciolino, MD, Mass. Eye and Ear - Suzanne Freitag, MD, Mass. Eye and Ear - Qin Liu, MD, PhD, Mass. Eye and Ear - Vincent Patalano, MD, Cambridge Health Alliance - Luk Vandenberghe, PhD, MSc, Mass. Eye and Ear - Michael Yoon, MD, Mass. Eye and Ear - Instructor in Ophthalmology: - Andrea Cruzat, MD, Schepens/Mass. Eye and Ear - Juan Ding, PhD, Schepens/Mass. Eye and Ear - Tobias Elze, PhD, Schepens/Mass. Eye and Ear - Ahmad Kheirkhah, MD, Schepens/Mass. Eye and Ear - Haijiang Lin, MD, PhD, Mass. Eye and Ear - Eleftherios Paschalis, PhD, MSc, Mass. Eye and Ear - Daniel Sun, PhD, OD, Mass. Eye and Ear - Xiaohong Zhou, MD, PhD, Mass. Eye and Ear - Cornea Center of Excellence hosts three days of unparalleled learning and discussion. The HMS Department of Ophthalmology Cornea Center of Excellence (COE) took center stage on October 17-19th when it hosted its first International Workshop at Mass. Eye and Ear followed by the 28th Biennial Cornea Conference held at the Schepens Starr Center for Scientific Communications. The inaugural International Workshop brought together a multidisciplinary group of more than 20 scholars. Both physicians and scientific researchers presented current research findings, exchanged scientific ideas, and strengthened international collaboration in the field of cornea and ocular surface research. The scientific program focused on virology, immune regulation, ocular surface, new imaging technologies, and regenerative medicine. Notably, Schepens alumnus and Professor and Chair of Ophthalmology at Kyoto Prefectural University of Medicine, Shigeru Kinoshita, MD, PhD, attended the workshop and also presented "Future Therapeutic Modalities for Devastating Ocular Surface and Corneal Disorders" during Grand Rounds earlier in the day. - The 4th Annual Mass. Eye and Ear Vitrectomy Course. The Course received unanimously positive feedback from this year's 48 fellows and six residents who attended from around the country. The free, two-day training intensive, held on July 19-20, 2013 attracted 33 world-class faculty members who joined together to deliver a brief, but comprehensive, introduction to the theory and practice of vitreoretinal surgery. Organized by Dean Eliott, MD, John Loewenstein, MD, and Demetrios Vavvas, MD, PhD, the course consisted of lectures, panel discussions, surgical simulation lab, and surgical wet lab in a setting with low student-to-teacher ratio. Emphasis on hands-on training and close interaction with faculty has made this course a tremendous success since its inauguration. All of the faculty have volunteered to return next year. since its inauguration. All of the faculty have volunteered to return next year. OTOLARYNGOLOGY: - Professor: - Christopher Shera, Ph.D. - Associate Professor: - Daniel Lee, M.D. - Assistant Professor: - Benjamin Bleier, M.D. - Robin Lindsay, M.D. - Stephane Maison, Ph.D. - Instructor (promoted from training status): - Mitchell Day, Ph.D. - Mingqian Huang, Ph.D. - Albena Kantardzhieva, Ph.D. - This year the department celebrated the class of 2013 at a June 21st ceremony held in the Meltzer auditorium. Our outstanding graduates included Drs. Sang Kim, Josh Meier, Daniel Roberts, and Josef Shargorodsky. We also welcomed five new residents to the program this year, Drs. Pete Creighton, Taha Jan, Brian Lin, Matthew Naunheim, and George Scangas. - The Department hosted the 12th International Facial Nerve Symposium over the weekend of June 28th, directed by Drs. Tessa Hadlock, Mack Cheney, and Michael McKenna. This four-day, lecture filled symposium included daily keynote addresses on topics ranging from facial nerve reconstruction to social functioning with facial paralysis. - A number of Mass. Eye and Ear physicians attended the International Federation of Otolaryngology Societies (IFOS) meetings in Seoul, Korea in May 2013, including Drs. Michael Rho, Eric Holbrook, Stacey Gray, Derrick Lin, James Rocco, Daniel Lee, Gregory Randolph, Nicolas Busaba, Phillip Song, Ramon Franco, and Head and Neck Surgical Oncology fellow Dr. Alice Lin. The group presented multiple lectures, panels, and courses to an international audience of otolaryngologists, with more than 4,500 attendees. The group plans to create an MEEI program for the next IFOS meeting in Paris in 2017. - Stacey Gray, M.D., was involved in a number of conferences in her field this year, serving as invited speaker and panel moderator for many of these engagements. This year she contributed to the Harvard Macy Institute Program for Educators in the Health Professions, the Combined Otolaryngology Spring Meeting in Orlando, the American Rhinology Society Summer Symposium in Chicago, the International Federation of Oto-Rhino-Laryngological Societies World Congress in Seoul, and the American Academy of Otolaryngology-Head and Neck Surgery Annual Meeting. - Christopher Halpin, Ph.D., delivered the keynote address at the Spanish Congress of Audiology, Royal College of Physicians, Seville, titled "Clinical word recognition and audiologic disorders." Dr. Halpin also spoke at the Sociedad Espanola de Otorrhinolaryngology in Madrid, Spain in 2013. - Eric Holbrook, M.D., has been invited to speak and serve as a faculty member for the European Rhinology Society/ISIAN Congress in Amsterdam in 2014. - Richard Lewis, M.D., was an invited speaker on "Central vestibular processing investigated with electrical stimulation of canal ampullary nerves," at the Sensing Motion for Action Symposium in Montreal in July 2013. Dr. Lewis also spoke on "Investigating vestibular function with perceptual threshold testing," at Spaulding Hospital in Boston in April 2013. - Daniel Polley, Ph.D., lectured at the February 2013 meeting for the Association of Research in Otolaryngology on cortical modulation of sound representations in the auditory thalamus. - Gregory Randolph, M.D., served as panel moderator of "Avoidance of Complication in Thyroid/Parathyroid Surgery," and as panelist for "Papillary Carcinoma: prophylactic central neck dissection" at the American Cancer Society meetings. Dr. Randolph also served on the steering committee for the 2nd World Congress on Thyroid Cancer, held in Toronto from July 10th through the 14th in 2013. The Congress is a global multidisciplinary meeting of all specialists involved in the treatment of thyroid nodule disease and thyroid cancer. - Konstantina Stankovic, M.D., Ph.D., presented at the February 2013 Association for Research in Otolaryngology (ARO) meeting on a selection of her unpublished work, including, "Loss of FGF23 signaling results in mixed hearing loss and middle ear malformation," "Molecular network analysis of hearing loss and hypogonadism," "Examining the role of Gtf2ird1 deletion in auditory physiology and behavior in a murine model of Williams-Beuren Syndrome," and "Finding characteristic DFNA9 cochlin-staining eosinophilic deposits in the middle ear." Dr. Stankovic also presented at the American Otologic Society and American Neurotology Society meetings in April 2013 on the following topics, "Metabolomics analysis of pharmacotherapies for sensorineural hearing loss," "Aspirin intake correlates with halted growth of sporatic vestibular schwannoma in vivo," and "Molecular network analysis of sporadic vestibular schwannoma pathobiology highlights actin as a major modulator of tumor growth." Radiology: - The radiologists wrote or participated in 34 papers including:Borodic GE, Caruso PA, Acquadro M, Chick S. "Parry-Romberg Syndrome Vasculopathy and its Treatment with Botulinum Toxin". Ophthal Plast Reconstr Surg May 2013. - Gao Y, Moonis G, Cunnane ME, Eisenberg RL. "Lacrimal Gland Masses". Am J Roentgenol 2013 Sep; 201(3):W371-81. - Lesnik D, Cunnane ME, Zurakowski D, Acar GO, Ecevit C, Mace A, Kamani D, Randolph GW. "Papillary Thyroid Carcinoma Nodal Surgery Directed by a Preoperative Radiographic Map Utilizing CT Scan and Ultrasound in all Primary and Reoperative Patients". Head Neck 2013 Apr; 2:232-77. - Quesnel AM, Moonis G, Appel J, O'Malley JT, McKenna MJ, Curtin HD, Merchant SN. "Correlation of Computed Tomography with Histopathology in Otosclerosis". Otol Neurotol 2013 Jan; 34(1):22-8. - Juliano AF, Ginat D, Moonis G. "Imaging Review of the Temporal Bone-Part I: Anatomy and Inflammatory and Neoplastic Processes". Radiol 2013 Oct; 269(1):17-33. - Ginat D, Freitag SK, Kieff D, Grove A, Fay A, Cunnane ME, Moonis G. "Radiographic Patterns of Orbital Involvement in IgG4-Related Disease". Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6. Ophthal Plast Reconstr Surg 2013 Jul-Aug; 29(4):261-6. FORM 990, PART III, LINE 4C: CLINICAL CARE Ophthalmology: - Mass. Eye and Ear, Longwood. Patient visits to the new Mass. Eye and Ear, Longwood multi-specialty ambulatory care center at 800 Huntington Avenue have climbed steadily since the facility opened its doors to patients in December, 2012. During 10 months in FY13, the Longwood medical team and staff handled nearly nine thousand patient visits. Four additional clinicians joined the practice this fall to keep pace with growth, bringing the number of Longwood practitioners to 13. Clinicians handle a full range of comprehensive and subspecialty services and the facility is fully equipped for surgery, procedures, imaging and diagnostics. The recent expansion to the Longwood Medical Area (LMA) has broadened and enhanced collaborations with LMA HMS Ophthalmology affiliates, neighborhood institutions and the community in general. Joslin Diabetes Center has co-located clinical offices there and Joslin physicians are now providing a full array of high quality, comprehensive and subspecialty eye care to ophthalmology patients who are at-risk for diabetes-related eye complications. Additionally, Mass. Eye and Ear, Longwood's closer proximity to Brigham and Women's (BWH) Hospital is speeding up communication with BWH physicians and the referral community, and providing faster access to care for patients. Led by Mass. Eye and Ear, Longwood Clinical Director, Carolyn Kloek, MD, several open houses were held before and after the Longwood facility opening to introduce the facility and staff to the neighboring hospital and referring physician community. Mass. Eye and Ear, Longwood is now well integrated into the community and is ready resource for nearby medical practices whose clinicians are operating in the facility's new surgical suite and utilizing its ophthalmic imaging and testing resources. - Mass. Eye and Ear and MGH Streamline Care for Patients with Diabetic Eye Disease. Mass. Eye and Ear and Mass General Hospital have collaborated to implement a new, streamlined patient care process for MGH patients who require an OPTOS diabetic eye screening or a diabetic eye exam. A Mass General PCP or nurse practitioner initiates testing by filling out a Mass. Eye and Ear order form and directs patients to Mass. Eye and Ear's Fluorescein Department. MGH patients are given the next available photographer for processing. Images are uploaded to the Mass. Eye and Ear image viewing system and a clinical message is posted in the LMR to alert the MDs reading the test. Once they review and document the result, a clinical message is sent to the referring PCP at Mass. General. Results are provided within one week and - in the event of an abnormal result - Mass. Eye and Ear staff will contact the patient to coordinate an appointment. Patients with normal studies are notified by mail or via Patient Gateway. - Mass. Eye and Ear Expands Optometry Team. Mass. Eye and Ear continues to grow its cadre of optometrists in a strategic move to extend its patient base, partner with MDs to optimize patient scheduling and streamline care to patients. The Optometry service now includes six, full-time members. The two most recent recruits to the service - Mark Bernardo, OD, and Yan Jiang, OD, PhD - have established full-time practices at Mass. Eye and Ear, Longwood. - Mass. Eye and Ear Ranked a Top Specialty Hospital. Since 1990, Mass. Eye and Ear has been one of the top ranked hospitals in the nation for ophthalmology, according to U.S. News & World Report magazine's "America's Best Hospitals" 2013 survey. This year, Mass. Eye and Ear, Massachusetts General Hospital ranked #4 in Ophthalmology. - Mass. Eye and Ear to Release the 4th Annual Quality and Outcomes Report. Mass. Eye and Ear prepared its 4th Annual Quality and Outcomes Report, documenting clinical and surgical outcomes data for key Ophthalmology procedures. The 2013 Quality and Outcomes Report (the third combined Ophthalmology/ENT report) will provide a full view of our highly specialized care and surgery, while cataloguing measures that continue to establish industry benchmarks nationwide. - New Equipment and Technology: - Retina Service: The next-generation Canon Adaptive Optics Scanning Laser Ophthalmoscope (not yet in clinical use) has the potential to resolve individual cone cells in the retina, enabling clinicians to monitor progression of diseases of the retina to a degree never before possible. - Retina/Glaucoma Service: TopCon Swept Source OCT allows the detection and resolution of individual retinal layers and is particularly helpful in retinal diseases such as wet AMD. This new technology has the potential to distinguish single photoreceptors in the retina with the potential for better resolution of sub-RPE images. COMMUNITY SERVICE: LOCAL/REGIONAL: - Support Groups - Mass. Eye and Ear Eye Plastics hosted a quarterly Thyroid Eye Disease support group, which is led by Suzanne Freitag, MD. This support group is run in collaboration with the Graves Disease and Thyroid Foundation along with MGH endocrinology and Dr. Greg Randolph of Mass. Eye and Ear ENT. - Mass. Eye and Ear Vision Rehabilitation Support Group runs weekly for 8 weeks in the Vision Rehabilitation Clinic, and is led by a Mass. Eye and Ear social worker and a social worker who has low vision. - Community Forums, Lectures and Special Events - Ula Jurkunas, MD, and Michael Young, PhD, presented a seminar entitled, "The Stem Cell Stories: Revolutionary Results from Boston-area Researchers," at a free public forum sponsored by the Harvard Stem Cell Institute as part of the International Society for Stem Cell Research's 11th Annual Meeting. The seminar was held at the OMNI Parker House in Boston on June 11, 2013. - On June 22, 2013 Lucy Shen, MD gave a talk to the New England Chapter of the Glaucoma Foundation on the importance and meaning of glaucoma tests. - Screenings - In conjunction with Vision Coalition, Mass. Eye and Ear provided dilated eye exams and eyeglasses for students from the Year Up program in July at both the main campus and at Longwood. Mark Bernardo, OD, Angela DuBois, Myrna Duran, Nolette Ferjuste, Alexander Lascko, Do Lee and Amy Watts, OD participated in this important program. - Community Benefits vision screenings for students at Camp Harbor View (18th Year) were held July 23 and August 9, 2013. Staff from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation screened 235 children in total, with 78 requiring follow-up care. - A team from Mass. Eye and Ear and Children's Hospital Ophthalmology Foundation visited the Neighborhood House Charter School on October 11, 2013 and provided more than 320 screenings. Mass. Eye and Ear has provided vision and hearing screenings to the children at this Boston school as part of its community benefits program since the school opened in 1995. Dr. Ankoor Shah and Chief Ophthalmic Tech, Shakhsanam Aliyeva led the team of residents, technicians and staff who helped with the event. OTOLARYNGOLOGY: - New Equipment and Technology: - An exciting milestone in our educational efforts, construction on our new state-of-the-art otolaryngology surgical training laboratory was completed early this year. The Joseph B. Nadol, Jr., M.D., Otolaryngology Surgical Training Laboratory allows for advanced instruction capabilities in nearly every subspecialty of otolaryngology and will serve as a resource for our residents and fellows, as well as experienced surgeons in continuing medical education. - Derrick Lin, M.D., and James Rocco, M.D., Ph.D., have pioneered efforts toward bringing transoral robotic surgery to appropriate head and neck cancer patients at Mass. Eye and Ear. Drs. Lin and Rocco now offer this treatment using facilities at Winchester Hospital, which is located in the northwest suburb of Boston. Radiology: - New Equipment and Technology: - A trial of a 3D Accuitomo CT system continued through FY13 and will continue in FY14. This is a no cost trial in an effort to work with the manufacturer to improve temporal bone scans and image resolution. Referring MD's have responded positively on the increased quality of images for these non-contrast studies. An evaluation to lease or purchase the system will be performed in FY14. - We are in the final evaluation stage to select a new CT system vendor (GE or Siemens) in an effort to replace the existing Siemens Somatom 40-slice CT system. The current system is nearing end of life and is approaching eight years old. The new CT system will be implemented in FY14. FORM 990, PART VI, LINE 1A: THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION"). FORM 990, PART VI, LINE 7B: THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY. FORM 990, PART VI, LINE 11B: THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING. FORM 990, PART VI, LINE 12C: MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH. FORM 990, PART VI, LINE 15: THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE. FORM 990, PART VI, LINE 19: SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: PERIODIC PENSION COST $11,881,769 FDN OF THE MASS EYE & EAR INFIRMARYINC 243 CHARLES STREET BOSTON MA 02114 042785453 PARENT MA 501(C)(3) 9 NA false MASSACHUSETTS EYE & EAR ASSOCIATES INC 243 CHARLES STREET BOSTON MA 02114 222658209 PATIENT CARE MA 501(C)(3) 9 FOUNDATION true CIRCLE COMPANY INC 243 CHARLES STREET BOSTON MA 02114 042801791 TITLE HOLDING MA 501(C)(25) N/A FOUNDATION true EMBANKMENT SERVICES INC 14 DAVID G MUGAR WAY BOSTON MA 02114 043272865 SUPPORTNG ORG MA 501(C)(3) 11 - TYPE 1 FOUNDATION true MASS EYE & EAR INFIRMARY PENSION PLAN 243 CHARLES STREET BOSTON MA 02114 046067238 PENSION PLAN MA 401(A) N/A NA false SCHEPENS EYE RESEARCH INSTITUTE INC 20 STANIFORD STREET BOSTON MA 02114 042129889 RESEARCH MA 501(C)(3) 7 FOUNDATION true false true true false false false false false false false true false true false true true true true false CIRCLE COMPANY INC K 25000 CASH CIRCLE COMPANY INC O 132054 CASH CIRCLE COMPANY INC Q 145000 CASH EMBANKMENT SERVICES INC Q 1170593 CASH EMBANKMENT SERVICES INC O 1389268 CASH MASSACHUSETTS EYE AND EAR PENSION PLAN R 8204000 CASH MASSACHUSETTS EYE AND EAR ASSOCIATES INC Q 28713700 CASH MASSACHUSETTS EYE AND EAR ASSOCIATES INC B 9966948 CASH MASSACHUSETTS EYE AND EAR ASSOCIATES INC C 80395 CASH SCHEPENS EYE RESEARCH INSTITUTE INC C 570606 CASH SCHEPENS EYE RESEARCH INSTITUTE INC Q 1124366 CASH SCHEPENS EYE RESEARCH INSTITUTE INC P 800674 CASH MASSACHUSETTS EYE AND EAR ASSOCIATES INC O 8739754 CASH SCHEDULE R, PART V, LINE 15: CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY.